Aldi

Aldi arrived as the Australian grocery landscape was consolidating: Franklins was collapsing and Bi-Lo was in decline, leaving a vacuum at the discount end of the market that Coles and Woolworths were happy to vacate. Aldi moved straight into that gap.

Aldi began on the east coast and expanded deliberately — store by store, funded from its own balance sheet rather than debt or franchising. It kept its proven limited-range formula largely intact: ~1,500 SKUs versus ~25,000 in a full-line supermarket, around 90% private label, small-format stores with minimal labour and quarter-sized footprints.

• Two stores on Australia Day weekend. Aldi opened its first two Australian stores simultaneously at Bankstown Airport and Marrickville in Sydney on 25 January 2001, with queues stretching around the buildings and through the car parks. By the end of 2001 it had 22 stores across NSW.
• A western Sydney nerve centre. The national head office sits at Minchinbury in Sydney's west, co-located with its first distribution region — Aldi runs Australia through regional distribution centres rather than a CBD corporate tower.
• Scale today. More than 570 stores and around 7,600 employees nationally, still without presence in Tasmania or the Northern Territory.

• Timing: entered as Franklins and Bi-Lo exited, inheriting the value-shopper segment
• Format discipline: never chased the majors on range; competed only on price and quality
• Patient capital: private ownership allowed a slow, profitable rollout over 20+ years rather than a land grab
• Localisation where it mattered: heavily Australian-sourced products under private labels, adapting buying without abandoning the model

• ~540 stores by August 2019, still no presence in Tasmania or the Northern Territory
• ~11–12.6% national grocery market share
• FY2025 sales of $13.94 billion, up 4.8%
• Profit fell ~20% in the 2026 supermarket price war — evidence that even the disruptor now shapes, and pays for, industry-wide price competition

Aldi shows that a foreign format can win in Australia without heavy localisation — if the entrant picks its moment, funds a patient rollout, and refuses to drift toward incumbents' playbooks.